Hepatitis B vaccine shortage: another symptom of chronic neglect?BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j4686 (Published 19 October 2017) Cite this as: BMJ 2017;359:j4686
- Philippa C Matthews, Wellcome Trust clinical research fellow and honorary consultant in infectious diseases and microbiology,
- Eleanor Barnes, professor of hepatology and experimental medicine and MRC senior fellow
- Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK
Current shortages of the hepatitis B virus vaccine have created media interest, including in The BMJ.1 Hepatitis B should make headlines; an estimated 250 million people are chronically infected, and funding, political advocacy, research, and clinical services have been neglected. International sustainable development goals aspire towards elimination of viral hepatitis as a public health threat by 2030.2 Vaccination is a crucial component of the multipronged effort needed to meet these targets.
Hepatitis B vaccine for routine infant vaccination …